Summary:
The purpose of the study is to determine if a new formulation of Rozerem is effective in treating symptoms of depression, associated with bipolar disorder. Rozerem is alreay approved by the FDA for the treatment of insomnia.
Get a second opinion, without getting stuck with a whopping bill.
See a psychiatrist without having to wait.
Compensation for your time and travel up to $1,060.00.
Free study-related medications and medical care and testing.
Participants in the Study will receive the following at no cost:
- Study-related procedures and medical care
- Study-related medication
- Compensation for your time and travel
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have been diagnosed with Bipolar I disorder